STEMXPAND
Dead / Cancelled — International registration cancelled — extension of protection cancelled (as of 08 May 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79114549
- Registration number
- 4362771
- Mark type
- Word mark
- Filed
- 07 May 2012
- Published for opposition
- 23 Apr 2013
- Registered
- 09 Jul 2013
- Attorney of record
- Jonathan Myers
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations intended for use in cell cultures; Cell culture media for cultivating stem cells; Growth media for cell growth, namely, culture media for cultivating stem cells intended for medical biotechnology; Biological reagents for molecular biology, chemical reagents for medical use for biological methods; Growth media adapted for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; Cellular function activating agents, namely, cell growth factors and hematopoietic factors; Medicated serums, namely, human serums for cell culture; Antibodies, namely, monoclonal antibodies for the selection and purification of stem cells; All of the aforementioned goods being for medical use
- Class 010 — Medical apparatus: Medical apparatus and instruments for use in cellular therapy, medical apparatus for cell cultivation, medical instruments for cell cultivation, medical apparatus and devices intended for cell separation techniques
- Class 042 — Scientific and technological services: Research and development of new products in the field of biotechnology, scientific analysis for medical purposes and the development of new products for medical research for thirds parties
- Class 044 — Medical, beauty and agricultural services: Medical care and treatment; Medical services, namely, cell collection, isolation and growth services for medical purposes; Medical analysis in connection with the treatment of individuals, namely, in vitro diagnostic, testing and statistic analysis of the patient status for medical purposes; Therapeutic treatments
Owner
- CELLPROTHERA, FR
- CELLPROTHERA, F-68200 Mulhouse, FR
- CELLPROTHERA, F-68200 Mulhouse, FR
Prosecution history
- 26 Nov 2022 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 26 Nov 2022 — DEATH OF INTERNATIONAL REGISTRATION
- 31 Aug 2022 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 24 Aug 2022 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 04 Jul 2022 — CORRECTION TRANSACTION RECEIVED FROM IB
- 03 Jul 2022 — LIMITATION OF GOODS RECEIVED FROM IB
- 29 Jun 2022 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 29 Jun 2022 — DEATH OF INTERNATIONAL REGISTRATION
- 25 Dec 2021 — REFUSAL PROCESSED BY IB
- 28 Nov 2020 — TOTAL INVALIDATION PROCESSED BY THE IB
- 04 Nov 2020 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 03 Nov 2020 — INVALIDATION PROCESSED
- 14 Oct 2020 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 14 Feb 2020 — CANCELLED SECTION 71
- 06 Feb 2020 — NEW REPRESENTATIVE AT IB RECEIVED